skip to main content
Idioma:
Mostrar Somente
Refinado por: Base de dados/Biblioteca: IngentaConnect Journals remover assunto: Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Prognostic Value of Pathologic Complete Response After Primary Chemotherapy in Relation to Hormone Receptor Status and Other Factors
Prognostic Value of Pathologic Complete Response After Primary Chemotherapy in Relation to Hormone Receptor Status and Other Factors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic Value of Pathologic Complete Response After Primary Chemotherapy in Relation to Hormone Receptor Status and Other Factors

GUARNERI, Valentina ; BROGLIO, Kristine ; GONZALEZ-ANGULO, Ana M ; KAU, Shu-Wan ; CRISTOFANILLI, Massimo ; BUZDAR, Aman U ; VALERO, Vicente ; BUCHHOLZ, Thomas ; MERIC, Funda ; MIDDLETON, Lavinia ; HORTOBAGYI, Gabriel N

Journal of clinical oncology, 2006-03, Vol.24 (7), p.1037-1044 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Sem texto completo

Citações Citado por
2
Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis
Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis

Marinovich, Michael L ; Macaskill, Petra ; Irwig, Les ; Sardanelli, Francesco ; Mamounas, Eleftherios ; von Minckwitz, Gunter ; Guarneri, Valentina ; Partridge, Savannah C ; Wright, Frances C ; Choi, Jae Hyuck ; Bhattacharyya, Madhumita ; Martincich, Laura ; Yeh, Eren ; Londero, Viviana ; Houssami, Nehmat

BMC cancer, 2015-10, Vol.15 (1), p.662-662, Article 662 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
3
Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): A European survey conducted by the European Society for Medical Oncology (ESMO) Young Oncologists Committee
Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): A European survey conducted by the European Society for Medical Oncology (ESMO) Young Oncologists Committee
Material Type:
Artigo 		Adicionar ao Meu Espaço

Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): A European survey conducted by the European Society for Medical Oncology (ESMO) Young Oncologists Committee

Califano, R ; Karamouzis, M.V ; Banerjee, S ; de Azambuja, E ; Guarneri, V ; Hutka, M ; Jordan, K ; Kamposioras, K ; Martinelli, E ; Corral, J ; Postel-Vinay, S ; Preusser, M ; Porcu, L ; Torri, V

Lung cancer (Amsterdam, Netherlands), 2014-07, Vol.85 (1), p.74-80 [Periódico revisado por pares]

Oxford: Elsevier

Texto completo disponível

Citações Citado por
4
Accelerated-Intensified Cyclophosphamide, Epirubicin, and Fluorouracil (CEF) Compared With Standard CEF in Metastatic Breast Cancer Patients: Results of a Multicenter, Randomized Phase III Study of the Italian Gruppo Oncologico Nord-Ouest–Mammella Inter Gruppo Group
Accelerated-Intensified Cyclophosphamide, Epirubicin, and Fluorouracil (CEF) Compared With Standard CEF in Metastatic Breast Cancer Patients: Results of a Multicenter, Randomized Phase III Study of the Italian Gruppo Oncologico Nord-Ouest–Mammella Inter Gruppo Group
Material Type:
Artigo 		Adicionar ao Meu Espaço

Accelerated-Intensified Cyclophosphamide, Epirubicin, and Fluorouracil (CEF) Compared With Standard CEF in Metastatic Breast Cancer Patients: Results of a Multicenter, Randomized Phase III Study of the Italian Gruppo Oncologico Nord-Ouest–Mammella Inter Gruppo Group

DEL MASTRO, Lucia ; VENTURINI, Marco ; COMIS, Silvia ; ROSSO, Riccardo ; LIONETTO, Rita ; CARNINO, Flavio ; GUARNERI, Domenico ; GALLO, Luigi ; CONTU, Antonio ; PRONZATO, Paolo ; VESENTINI, Lorella ; BERGAGLIO, Marina

Journal of clinical oncology, 2001-04, Vol.19 (8), p.2213-2221 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Sem texto completo

Citações Citado por
5
Prophylaxis of superficial bladder cancer with mitomycin or interferon alfa-2b: results of a multicentric Italian study
Prophylaxis of superficial bladder cancer with mitomycin or interferon alfa-2b: results of a multicentric Italian study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prophylaxis of superficial bladder cancer with mitomycin or interferon alfa-2b: results of a multicentric Italian study

BOCCARDO, F ; CANNATA, D ; SALVIA, G ; COMERI, G ; BONO, A ; BORELLA, T ; GIULIANI, L ; RUBAGOTTI, A ; GUARNERI, D ; DECENSI, A ; CANOBBIO, L ; CUROTTO, A ; MARTORANA, G ; PEGORARO, C ; SELVAGGI, F

Journal of clinical oncology, 1994-01, Vol.12 (1), p.7-13 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Sem texto completo

Citações Citado por
6
Long-acting (depot) D-TRP-6 LH-RH (Decapeptyl) in prostate cancer. An Italian multicentric trial
Long-acting (depot) D-TRP-6 LH-RH (Decapeptyl) in prostate cancer. An Italian multicentric trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Long-acting (depot) D-TRP-6 LH-RH (Decapeptyl) in prostate cancer. An Italian multicentric trial

Boccardo, F ; Decensi, A ; Guarneri, D ; Rubagotti, A ; Martorana, G ; Giberti, C ; Cerruti, G B ; Tani, F ; Zanollo, A ; Germinale, T

American journal of clinical oncology, 1988, Vol.11 Suppl 2, p.S129-131 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
7
Recombinant alpha-2a interferon plus vinblastine in the treatment of metastatic renal cell carcinoma
Recombinant alpha-2a interferon plus vinblastine in the treatment of metastatic renal cell carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Recombinant alpha-2a interferon plus vinblastine in the treatment of metastatic renal cell carcinoma

Sertoli, M R ; Brunetti, I ; Ardizzoni, A ; Falcone, A ; Guarneri, D ; Boccardo, F ; Martorana, G ; Curotto, A ; Sicignano, A ; Rosso, R

American journal of clinical oncology, 1989-02, Vol.12 (1), p.43 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Mostrar Somente

  1. Recursos Online (4)

Data de Publicação 

De até
Refinar
  1. Antes de1988  (1)
  2. 1988Até1988  (1)
  3. 1989Até1993  (1)
  4. 1994Até2001  (2)
  5. Após 2001  (3)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.